Cancer

Apr 02, 2019

Selumetinib gets the U.S. Breakthrough Therapy Designation Selumetinib- an investigational drug, for the treatment of pediatric patients aged three years and above suffering from symptomatic and/or progressive, inoperable neurofibromatosis type 1 (NF1), plexiform neurofibromas (PN)- a rare genetic condition, has...

Mar 26, 2019

Laminin might help to regenerate heart muscles Researchers at Duke-NUS Medical School, Singapore, have been studying the self-regeneration process of the heart. After an injury, the self- regeneration property of the heart has been limited. But now, Scientists turned to Stem Cell therapy. They are prepping stem ...

Mar 12, 2019

Stemline gives in-licenses global rights to SL-1001 Stemline Therapeutics, Inc. is a biopharmaceutical company focused on development and commercialization of novel oncology therapeutics, has licensed worldwide rights to a preclinical molecule RET (rearranged during transfection) kinase inhibitor. The RET kinase...

Feb 22, 2019

Cholangiocarcinoma (BILE Duct cancer) is a type of uncommon CANCER. It arises in Bile ducts. The Bile duct is a long tubule like structure which connects the liver (hepatic duct) to the gall bladder (cystic duct). It carries bile, which helps in digestion of food, from gall-bladder (produced in the liver) to inte...

Feb 21, 2019

Peloton Therapeutics raises USD 150 Million for treating Advance Kidney Cancer Peloton Therapeutics has been in the process of developing small molecule drugs to treat Cancer, has raised USD 150 million. Peloton’s lead therapeutic candidate, PT2977, focuses on targeting hypoxia-inducible fac...

Feb 19, 2019

CRISPR treatment delivers benefits in mice The researchers from Duke University along with drugmaker Sarepta Therapeutics published a report stating that a single change in the genetic system of Duchenne muscular dystrophy (DMD) affected mice, using CRISPR gene editing tool resulted in increasing their life spa...

Jan 18, 2019

Doctors now have a new weapon in the fight against cancer: detailed maps of the cells in a tumour that can be explored and analyzed in a virtual reality simulation that its creators say provides researchers with an intuitive new way to examine complex medical data that could lead to unexpected breakthroughs. Bui...

Jan 16, 2019

A survey was done in which thousands of advanced cancers indicated a way to detect those that respond to revolutionary therapies that unleash an immune response against tumours. However, the results show difficulty level to translate an approach into a reliable clinical test. The findings are the latest evidence to...

Jan 04, 2019

In what could be regarded as a first of its kind, researchers from the Centre for Vision, Speech and Signal Processing at the University of Surrey in the United Kingdom have recently reported that they created two machine learning models that are able to precisely predict the severity of three common symptoms ...

Dec 17, 2018

In a groundbreaking clinical trial, a 66-year-old Ohio woman became the first patient to become cancer free through the CAR T Cell Therapy. In August this year, Denise Kennan had participated in the cancer treatment trial at the Seidman Cancer Center in University Hospitals of Cleveland; following which 30 days late...